Background illustration for clinical trials search

Stem Cells Clinical Trials

Find clinical trials for stem cells. Search for stem cells clinical trials in different cities and states across the United States.

Filter

Feasibility and Acceptability of Primary Palliative Care Intervention in Patients Undergoing Hematopoietic Stem Cell Transplantation

for
Hematopoietic Cell Transplant, Hematologic Malignancy
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT06676852

Recruiting

Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease

for
Huntington Disease
Location: Irvine CA
Sponsor: Leslie Thompson

Sex: All

Age: 18 - 65

Code: NCT07451613

Phase1, Phase2, Recruiting

Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant

for
Multiple Myeloma, Plasma Cell Leukemia
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT05405387

Phase2, Recruiting

Pacritinib With Standard of Care Azacitidine or Decitabine as a Bridge to Allogeneic Hematopoietic Stem Cell Transplant for Patients With Accelerated and Blast Phase Myeloproliferative Neoplasms

for
Accelerated Phase Myeloproliferative Neoplasm,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT07148947

Phase2, Recruiting

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Philadelphia PA, Wilmington DE, Baltimore MD, Miami FL,
Sponsor: Children's Oncology Group

Sex: All

Age: 2 - 18

Code: NCT05711667

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

for
T-cell Lymphoma, Graft Versus Host Disease, Lymphoma, T-Cell,
Location: Columbus OH
Sponsor: Jonathan Brammer

Sex: All

Age: 18+

Code: NCT07356245

Phase2, Recruiting

Mozobil for Autologous Hematopoietic Stem Cell Transplantation

for
Multiple Myeloma, Hodgkin Lymphoma, Non-hodgkin Lymphoma
Location: Philadelphia PA
Sponsor: Thomas Jefferson University

Sex: All

Age: 18+

Code: NCT07188090

Phase2, Recruiting

Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial

for
Multiple Myeloma
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT07101445

Recruiting

hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)

for
Glioblastoma Multiforme, Glioblastoma Multiforme, Adult,
Location: Cleveland OH
Sponsor: Leland Metheny

Sex: All

Age: 18+

Code: NCT05052957

Phase2, Recruiting

A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

for
AML, MDS
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: TScan Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07702578

Phase3, Recruiting

Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

for
Leukemia, Lymphoma, Hematologic Malignancy
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT06856226

Recruiting

Mobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS)

for
Diamond Blackfan Anemia
Location: New Hyde Park NY
Sponsor: Northwell Health

Sex: All

Age: 3 - 30

Code: NCT07186179

Recruiting

Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma

for
Recurrent Group 3 Medulloblastoma,
Location: Gainesville FL
Sponsor: University of Florida

Sex: All

Age: 4 - 30

Code: NCT06514898

Phase1, Recruiting

Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors

for
Sickle Cell Disease, Beta-thalassemia
Location: Bethesda MD
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All

Age: 4 - 65

Code: NCT07599176

Phase1, Phase2, Recruiting

Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes

for
Granuloma, Granulomatous Disease, Chronic, Leukocyte Disease,
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 70

Code: NCT00001405

Recruiting

Stem Cell Therapy for Early Alzheimer's Disease

for
Cognitive Dysfunction
Location: Houston TX
Sponsor: Paul E Schulz

Sex: All

Age: 60 - 70+

Code: NCT06775964

Phase1, Phase2, Recruiting

Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant

for
Myeloid Malignancy, Acute Myeloid Leukemia
Location: Cleveland OH
Sponsor: Benjamin Tomlinson

Sex: All

Age: 18+

Code: NCT06129734

Phase1, Phase2, Recruiting

Base Editing Hematopoietic Stem Cell and T Cell Gene Therapy for CD40L-HyperIgM Syndrome: Single Patient Study

for
CD40L-HyperIgM Syndrome
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: Male

Age: 37 - 70+

Code: NCT06959771

Phase1, Phase2, Recruiting

131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)

for
Sickling Disorder Due to Hemoglobin S
Location: New York NY
Sponsor: Columbia University

Sex: All

Age: 12 - 50

Code: NCT07015684

Phase1, Recruiting

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

for
Multiple Myeloma, Newly Diagnosed Multiple Myeloma
Location: Saint John, Portland ME, Providence RI, Worcester MA,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06679101

Phase3, Recruiting

What are stem cell clinical trials?

Stem cell clinical trials are research studies that explore the therapeutic potential of stem cells for treating a wide range of diseases and conditions. These trials investigate various types of stem cells, including embryonic stem cells, induced pluripotent stem cells (iPSCs), mesenchymal stem cells (MSCs), hematopoietic stem cells (HSCs), and adipose-derived stem cells. These trials aim to develop treatments for a wide range of conditions, such as cardiovascular diseases, neurological disorders, autoimmune diseases, orthopedic injuries, Alzheimer's disease, Crohn's disease and cancer.

Importance of clinical trials for stem cells

Clinical trials for stem cells are crucial for advancing regenerative medicine and offering hope for patients with conditions that are currently difficult to treat. These studies help to determine the safety, efficacy, and optimal use of stem cell therapies, potentially leading to breakthroughs in the treatment of chronic diseases, immune disorders, and injuries. They play a vital role in understanding how stem cells can be used to repair damaged tissues, treat malignancies, and improve patient outcomes.

Types of interventions studied in stem cells clinical trials

Eligibility and participation in stem cells clinical trials

How to enroll in a stem cell clinical trial